🇺🇸 FDA
Patent

US 11692027

Antibody and protein therapeutic formulations and uses thereof

granted A61KA61K38/063A61K38/179

Quick answer

US patent 11692027 (Antibody and protein therapeutic formulations and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/063, A61K38/179, A61K39/39591, A61K47/10